drugset / Trial / NCT01515917

Citicoline and Omega-3 Fatty Acid Effects in Veterans With Traumatic Brain Injury (TBI)

NCT01515917

RandomizedParallel-groupTriple-blindTreatment

Summary

This is a placebo-controlled study intended to examine the effects of the neutraceutical citicholine, together with omega-3 fatty acids, on a range of measures in individuals with concussive head injury, often referred to as traumatic brain injury, or TBI. The study will consist of three visits, during which participants will complete brain scans, a thorough testing battery and a clinical interview to assess mood and other diagnostic information relevant to the study.

Timeline

Start
2013-11
Primary completion
2016-07
Completion
2017-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Citicoline Other / unclassified 1000 mg Oral
Subject Omega-3 fatty acids Unknown 2000 mg Oral